Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQ2P1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,846
Award facts
- Contract value 100% obligated
- $25,845.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,845.75 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive, firm fixed-price contract was issued without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to deliver a broad range of pharmaceutical products across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, represents one of the specialized medications within AmerisourceBergen's extensive federal medical supply portfolio.
Quick answers
Who was awarded contract SPE2DB25FQ2P1?
SPE2DB25FQ2P1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FQ2P1 worth?
The government has obligated $25,846 on SPE2DB25FQ2P1.
Is contract SPE2DB25FQ2P1 an order under another contract?
Yes. SPE2DB25FQ2P1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ2P1 competed?
The extent of competition for SPE2DB25FQ2P1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award